Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who are ...
A new lawsuit seeks to overturn the recent approval of an exploratory drilling program in the National Petroleum ...